* Receives ANDA approval for nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/g Source text: http://bit.ly/2faznIz Further company coverage: (Bengaluru newsroom)
BRIEF-Hubei Jumpcan Pharmaceutical says controlling shareholder to transfer 12.4 pct stake in the co
* Says its controlling shareholder to transfer 100 million shares (12.4 percent stake) of the co to the controlling shareholder's wholly owned subsidiary
* Says it completes around 20.2 million shares' buy-back for approximately 50 billion yen as of Oct. 24
Oct 24 Merck & Co Inc on Monday said the U.S. Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously untreated lung cancer patients, making it the only approved first-line treatment.
* Seeks trading halt pending release of an ASX announcement regarding a capital raising Source text for Eikon: Further company coverage:
No related earnings announcements are currently scheduled within the next 7 days.